Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review.

The Lancet. Microbe - 1 May 2022

Rhee Soo-Yon, Kassaye Seble G, Jordan Michael R, Kouamou Vinie, Katzenstein David, Shafer Robert W

Abstract excerpt

HIV-1 pol sequences from antiretroviral therapy (ART)-naive and ART-experienced people living with HIV-1 are fundamental to understanding the genetic correlates and epidemiology of HIV-1 drug resistance (HIVDR). To assess the public availability of HIV-1 pol sequences and ART histories of the individuals from whom sequenced viruses were obtained, we performed a systematic review of PubMed and GenBank for HIVDR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Anti-HIV Agents
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to HIV Seropositivity

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 35544100
DOI: 10.1016/S2666-5247(21)00250-0
PMCID: PMC9095989

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review.PMID 35544100Read ↗

Recommendations on data sharing in HIV drug resistance research.Semantic proximity Read ↗

The global burden of HIV-1 drug resistance in the past 20 yearsSemantic proximity Read ↗

HIV-1 drug resistance and resistance testing.Semantic proximity Read ↗

HIV-1 Drug Resistance Trends in the Era of Modern Antiretrovirals: 2018–2024Semantic proximity Read ↗

Impact of human immunodeficiency virus type-1 sequence diversity on antiretroviral therapy outcomes.Semantic proximity Read ↗

HIV-1 Drug Resistance among Treatment-Naïve Patients in Russia: Analysis of the National Database, 2006-2022.Semantic proximity Read ↗

Evaluation of HIV-1 antiretroviral drug resistance profiles in the peripheral blood reservoir of successfully treated persons using massive sequencing and viral full genome characterization.Semantic proximity Read ↗

Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-2018.Semantic proximity Read ↗

Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV.Semantic proximity Read ↗

HIV primary drug resistance and associated HIV risk factors among HIV positive blood donors in Brazil from 2007 to 2017.Semantic proximity Read ↗

Protease and Gag Diversity and Drug Resistance Mutations Among Treatment-Naive Mexican People Living with HIVSemantic proximity Read ↗

Human Immunodeficiency Virus Type-1 Genetic Diversity and Drugs Resistance Mutations among People Living with HIV in Karachi, Pakistan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.